By Avi Kapoor
Publication Date: 2025-12-09 14:17:00
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- RBC Capital raised Wave Life Sciences Ltd. (NASDAQ:WVE) price target from $9 to $27. RBC Capital analyst Luca Issi upgraded the stock from Sector Perform to Outperform. Wave Life Sciences shares closed at $18.52 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. boosted the price target for Terns Pharmaceuticals, Inc. (NASDAQ:TERN) from $20 to $60. HC Wainwright & Co. analyst Andres Y. Maldonado maintained a Buy rating. Terns Pharmaceuticals shares closed at $40.23 on Monday. See how other analysts view this stock.
- BTIG increased Kymera Therapeutics, Inc. (NASDAQ:KYMR) price target from $75 to $138. BTIG analyst Jeet Mukherjee maintained a Buy rating. Kymera Therapeutics shares closed at $94.30 on Monday. See how other analysts view this stock.
- RBC Capital increased…